Icra sees pharma industry growth tapering to 7-10% over FY18-FY20Post published:July 4, 2017Post category:Industry NewsThe Indian pharma industry is likely to witness a slowdown in growth because of pricing pressure and regulatory interventions in the US, according to an Icra report Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostIndoStar Capital close to acquiring ICICI Home Finance Next PostGST rates: Footwear to cost more as firms look to increase prices by 5-7% You Might Also Like US judge sets $30,000 bail for UK hacker Marcus Hutchins, who stopped WannaCry ransomware August 5, 2017 AVEVA announces winners of competition for Chemical Engineering students May 8, 2019 New York wants Amazon’s new headquarters, says city beats suburbs September 16, 2017
US judge sets $30,000 bail for UK hacker Marcus Hutchins, who stopped WannaCry ransomware August 5, 2017